Would the merge-and-assist clause in OpenAI’s charter violate Section 7 of the Clayton Act?
My understanding is that ifthe DOJ and FTC choose not to challenge a merger, the merger may proceed unless another party successfully challenges it. But I’m still confused about some open questions:
How should the relevant market be defined?
Would frontier AI labs constitute a distinct antitrust market?
How would market concentration (HHI) be measured?
How should innovation competition be analysed?
Could AI safety benefits qualify as merger efficiencies?
The GPT 5.5/5.6 models score very competitively on security-agent benchmarks like ExploitBench, but it’s possible a small advantage could snowball. I’m surprised that the SpaceXAI-Anthropic compute partnership happened, and Demis Hassabis’s “A Framework for Frontier AI and the Dawning of a New Age” (Jul 14) speaks of competitive dynamics in a way that makes me think about a hypothetical DeepMind-OpenAI consolidation.
Also, could U.S frontier labs merge with their Chinese counterparts (e.g as part of a coordinated slowdown)?
Would the merge-and-assist clause in OpenAI’s charter violate Section 7 of the Clayton Act?
My understanding is that if the DOJ and FTC choose not to challenge a merger, the merger may proceed unless another party successfully challenges it. But I’m still confused about some open questions:
How should the relevant market be defined?
Would frontier AI labs constitute a distinct antitrust market?
How would market concentration (HHI) be measured?
How should innovation competition be analysed?
Could AI safety benefits qualify as merger efficiencies?
The GPT 5.5/5.6 models score very competitively on security-agent benchmarks like ExploitBench, but it’s possible a small advantage could snowball. I’m surprised that the SpaceXAI-Anthropic compute partnership happened, and Demis Hassabis’s “A Framework for Frontier AI and the Dawning of a New Age” (Jul 14) speaks of competitive dynamics in a way that makes me think about a hypothetical DeepMind-OpenAI consolidation.
Also, could U.S frontier labs merge with their Chinese counterparts (e.g as part of a coordinated slowdown)?